Diagnostic Evaluation and Monitoring of Patients With Posterior Cortical Atrophy

References

• Benson DF , DavisRJ, SnyderBD. Posterior cortical atrophy. Arch. Neurol., 45(7), 789–793 (1988).
   PubMedGoogle Scholar
• Tang-Wai DF , LakeA, Graff-RadfordN. Posterior cortical atrophy. In: Dementia: Comprehensive Principles and Practice. Dickerson BC, Atri A (Eds). Oxford University Press, NY, USA210–221 (2014).
   Google Scholar
• Levine DN , LeeJM, FisherCM. The visual variant of Alzheimer’s disease: a clinicopathologic case study. Neurology, 43(2), 305–313 (1993).
   PubMed Web of Science ®Google Scholar
• Mendez MF , GhajaraniaM, PerrymanKM. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer’s disease. Dement. Geriatr. Cogn. Disord., 14(1), 33–40 (2002).
   PubMed Web of Science ®Google Scholar
• Tang-Wai DF , Graff-RadfordNR, BoeveBFet al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology, 63(7), 1168–1174 (2004).
   PubMed Web of Science ®Google Scholar
• Renner JA , BurnsJM, HouCEet al. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology, 63(7), 1175–1180 (2004).
   PubMed Web of Science ®Google Scholar
• McKhann GM , KnopmanDS, ChertkowHet al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimers Dement., 7(3), 263–269 (2011).
   PubMed Web of Science ®Google Scholar
• Crutch SJ , SchottJM, RabinoviciGDet al. Shining a light on posterior cortical atrophy. Alzheimers Dement., 9(4), 463–465 (2013).
   PubMed Web of Science ®Google Scholar
• Crutch SJ , SchottJM, RabinoviciGDet al. Consensus classification of posterior cortical atrophy. Alzheimers Dement., 13(8), 870–884 (2017).
   PubMed Web of Science ®Google Scholar
• Alladi S , XuerebJ, BakTet al. Focal cortical presentations of Alzheimer’s disease. Brain, 130(Pt 10), 2636–2645 (2007).
   PubMed Web of Science ®Google Scholar
• Mitchell SB , LucenteD, LarvieMet al. A 63-year-old man with progressive visual symptoms. JAMA Neurol., 74(1), 114–118 (2017).
   PubMed Web of Science ®Google Scholar
• Caroppo P , BelinC, GrabliDet al. Posterior cortical atrophy as an extreme phenotype of GRN mutations. JAMA Neurol., 72(2), 224–228 (2015).
   PubMed Web of Science ®Google Scholar
• Snowden JS , StopfordCL, JulienCLet al. Cognitive phenotypes in Alzheimer’s disease and genetic risk. Cortex, 43(7), 835–845 (2007).
   PubMed Web of Science ®Google Scholar
• Kas A , Cruzde Souza L, SamriDet al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain, 134, 1464–1478 (2011).
   PubMed Web of Science ®Google Scholar
• Crutch SJ , LehmannM, SchottJMet al. Posterior cortical atrophy. Lancet Neurol., 11(2), 170–178 (2012).
   PubMed Web of Science ®Google Scholar
• McKhann GM , DrachmanD, FolsteinMet al. Clinical diagnosis of Alzheimer’s disease: report of the NIINCDS-ARDA work group under the auspices of Department of Health and Human Services Task Force on Azlheimer’s disease. Neurology, 34(7), 939–944 (1984).
   PubMed Web of Science ®Google Scholar
• Albert MS , DeKoskyST, DicksonDet al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement., 7(3), 270–279 (2011).
   PubMed Web of Science ®Google Scholar
• Dickerson BC , McGinnisSM, XiaCet al. Approach to atypical Alzheimer’s disease and case studies of the major subtypes. CNS Spectrums, 22(6), 439–449 (2017).
   PubMed Web of Science ®Google Scholar
• Rusconi E , PinelP, DehaeneS, KleinschmidtA. The enigma of Gerstmann’s syndrome revisited: a telling tale of the vicissitudes of neuropsychology. Brain, 133(Pt 2), 320–332 (2010).
   PubMedGoogle Scholar
• Mendez MF , ShapiraJS, ClarkDG. Apperceptive alexia in posterior cortical atrophy. Cortex, 43(2), 264–270 (2007).
   PubMed Web of Science ®Google Scholar
• Crutch SJ , LehmannM, WarrenJD, RohrerJD. The language profile of posterior cortical atrophy. J. Neurol. Neurosurg. Psych., 84(4), 460–466 (2013).
   PubMed Web of Science ®Google Scholar
• Ahmed S , BakerI, HusainMet al. Memory impairment at initial clinical presentation in posterior cortical atrophy. J. Alzheimers Dis., 52(4), 1245–1250 (2016).
   PubMed Web of Science ®Google Scholar
• Farias ST , MungasD, ReedBRet al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology, 22(4), 531–544 (2008).
   PubMed Web of Science ®Google Scholar
• Pfeffer RI , KurosakiTT, HarrahCH Jret al. Measurement of functional activities in older adults in the community. J. Gerontol., 37(3), 323–329 (1982).
   PubMedGoogle Scholar
• Johnson N , BarionA, RademakerA, RehkemperG, WeintraubS. The activities of daily living questionnaire: a validation study in patients with dementia. Alzheimer Dis. Assoc. Disord., 18(4), 223–230 (2004).
   PubMed Web of Science ®Google Scholar
• Da Silva MNM , MillingtonRS, BridgeH, James-GaltonM, PlantGT. Visual dysfunction in posterior cortical atrophy. Front. Neurol., 8, 389 (2017).
   PubMed Web of Science ®Google Scholar
• Chan LTA , LynchW, DeMay M, HortonJC, MillerBL, RabinoviciGD. Prodromal posterior cortical atrophy: clinical, neurosychological, and radiological correlation. Neurocase, 21(1), 44–55 (2015).
   PubMed Web of Science ®Google Scholar
• Cordano C , AlessandriaG, LeonardiAet al. Homonymous hemianopia as the first sign of posterior cortical atrophy. J. Neurol. Sci., 373, 38–40 (2017).
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS , PhillipsNA, BedirianVet al. The Montreal Cognitive Assessment, MOCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc., 53(4), 695–699 (2005).
   PubMed Web of Science ®Google Scholar
• Wechsler D . Wechsler Adult Intelligence Scale – Fourth Edition (WAIS–IV).Pearson, TX, USA (2008).
   Google Scholar
• Pearson Assessment . Advanced Clinical Solutions for the WAIS-IV and WMS-IV: Clinical and Interpretive Manual.Pearson, TX, USA (2009).
   Google Scholar
• Crawford JR , DearIJ, StarrJ, WhaleyLJ. The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year-interval. Psychol. Med., 31(3), 451–458 (2001).
   PubMed Web of Science ®Google Scholar
• Jones BN , TengEL, FolsteinMF, HarrisonKS. A new bedside test of cognition for patients with HIV infection. Ann. Intern. Med., 119(10), 1001–1004 (1993).
   PubMed Web of Science ®Google Scholar
• Delis D , KaplanE, KramerJet al.et al. ( Eds). Delis–Kaplan Executive Functioning Scale.The Psychological Corporation, TX, USA (1997).
   Google Scholar
• Hamberger MJ , SeidelWT. Auditory and visual naming tests: normative and patient data for accuracy, response time, and tip-of-the-tongue. J. Int. Neuropsychol. Soc., 9, 479–489 (2003).
   PubMed Web of Science ®Google Scholar
• Goodglass H , KaplanE, BarressiB ( Eds). Boston Diagnostic Aphasia Examination (3rd Edition).Lippincott Williams & Wilkins, PA, USA (2001).
   Google Scholar
• McMonagle P , DeeringF, BerlinerY, KerteszA. The cognitive profile of posterior cortical atrophy. Neurology, 66(3), 331–338 (2006).
   PubMed Web of Science ®Google Scholar
• Lehmann M , CrutchS, RidgwayGRet al. Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer’s disease. Neurobiol. Aging, 32, 1466–1476 (2011).
   PubMed Web of Science ®Google Scholar
• Riddoch MJ , HumphreysGW BORB: Birmingham Object Recognition Battery. Lawrence Erlbaum, NJ, USA (1993).
   Google Scholar
• Warrington EK , JamesM. Visual Object and Space Perception Battery (VOSP).Pearson, Cambridge, UK (1991).
   Google Scholar
• Benton A , SivanA, HamsherKet al.et al. ( Eds). Contributions to Neuropsychological Assessment (2nd Edition).Oxford University Press, NY, USA (1994).
   Google Scholar
• Jackson M , WarringtonE. Arithmetic skills in patients with unilateral cerebral lesions. Cortex, 22(4), 611–620 (1986).
   PubMed Web of Science ®Google Scholar
• Suárez-González A , CrutchSJ, Franco-MacíasE, Gil-NécigaE. Neuropsychiatric symptoms in posterior cortical atrophy and Alzheimer disease. J. Geriatric Psych. Neurol., 29(2), 65–71 (2015).
   PubMed Web of Science ®Google Scholar
• Isella V , VillaG, MapelliC, FerriF, AppollonioIM, FerrareseC. The neuropsychiatric profile of posterior cortical atrophy. J. Geriatric Psych. Neurol., 28(2), 136–144 (2015).
   PubMed Web of Science ®Google Scholar
• Everhart DE , HighsmithJM, DavisCE. Posterior cortical atrophy: a case study of Benson’s syndrome that initially presented as anxiety disorder. App. Neuropsychol. Adult, 19(3), 229–236 (2012).
   PubMed Web of Science ®Google Scholar
• Wolf R , Schonfeldt-LecuonaC. Depressive symptoms as first manifestation of posterior cortical atrophy. Am. J. Psych., 163(5), 939–940 (2006).
   PubMed Web of Science ®Google Scholar
• Josephs KA , WhitwellJL, BoeveBFet al. Visual hallucinations in posterior cortical atrophy. Arch. Neurol., 63(10), 1427–1432 (2006).
   PubMedGoogle Scholar
• Cummings JL , MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2314 (1994).
   PubMed Web of Science ®Google Scholar
• Kaufer DI , CummingsJL, KetchelPet al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J. Neuropsych. Clin. Neurosci., 12(2), 233–239 (2000).
   PubMed Web of Science ®Google Scholar
• Yesavage JA , BrinkTL, RoseTLet al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res., 17(1), 37–49 (1982).
   PubMed Web of Science ®Google Scholar
• Wear H , WedderburnC, MioshiEet al. The Cambridge behavioural inventory revised. Dement. Neuropsychol., 2(2), 102–107 (2008).
   PubMedGoogle Scholar
• Möller C , vander Flier WM, VersteegAet al. Quantitative regional validation of visual rating scale for posterior cortical atrophy. Eur. Radiol., 24(2), 397 (2014).
   PubMed Web of Science ®Google Scholar
• Shaw LM , VandersticheleH, Knapik-CzajkaMet al. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann. Neurol., 65(4), 403–413 (2009).
   PubMed Web of Science ®Google Scholar
• Wellington H , PatersonRW, Suárez-GonzálezAet al. CSF neurogranin or tau distinguish typical and atypical Alzheimer disease. Ann. Clin. Transl. Neurol., 5(2), 162–171 (2018).
   PubMed Web of Science ®Google Scholar
• Paterson RW , ToombsJ, SlatteryCFet al. Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis. J. Neurol., 262(12), 2722 (2015).
   PubMed Web of Science ®Google Scholar
• Johnson KA , MinoshimaS, BohnenNIet al. Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Alzheimers Dement., 9(4), e106–e109 (2013).
   PubMedGoogle Scholar
• Kennedy J , LehmannM, SokolskaMJet al. Visualizing the emergence of posterior cortical atrophy. Neurocase, 18(3), 248–257 (2012).
   PubMed Web of Science ®Google Scholar
• Lehmann M , BarnesJ, RidgwayGRet al. Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimers Dement., 8(6), 502–512 (2012).
   PubMed Web of Science ®Google Scholar
• Wylie MA , ShnallA, OnyikeCU, HueyED. Management of frontotemporal dementia in mental health and multidisciplinary settings. Int. Rev. Psych., 25(2), 230–236 (2013).
   Google Scholar
• Cardarelli R , KerteszA, KneblJA. Frontotemporal dementia: a review for primary care physicians. Am. Fam. Physician, 82(11), 1372–1377 (2010).
   PubMed Web of Science ®Google Scholar
• Ridha BH , CrutchS, CutlerDet al. A double-blind placebo-controlled cross-over clinical trial of DONepezil in posterior cortical atrophy due to underlying Alzheimer’s Disease: DONIPAD study. Alzheimers Res. Ther., 10(1), 44 (2018).
   PubMed Web of Science ®Google Scholar
• Seitz DP , AdunuriN, GillSS, GruneirA, HerrmannN, RochonP. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst. Rev., 2011(2), CD008191 (2011).
   Google Scholar
• Lyketsos CG , LopezO, JonesB, FitzpatrickAL, BreitnerJ, DeKoskyS. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. JAMA, 288(12), 1475 (2002).
   PubMed Web of Science ®Google Scholar
• Porsteinsson AP , TariotPN, ErbRet al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am. J. Geriatr. Psych., 9(1), 58–66 (2001).
   PubMed Web of Science ®Google Scholar
• Schneider LS , DagermanKS, InselP. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294(15), 1934–1943 (2005).
   PubMed Web of Science ®Google Scholar
• Campbell JJ , NgoG. Risperidone treatment of complex hallucinations in a patient with posterior cortical atrophy. J. Neuropsych. Clin. Neurosci., 20(3), 378–379 (2008).
   PubMed Web of Science ®Google Scholar
• Alves J , MagalhaesR. Cognitive rehabilitation in a visual variant of Alzheimer’s disease. App. Neuropsychol. Adult, 22(1), 73–78 (2015).
   PubMed Web of Science ®Google Scholar
• Roca M , GleichgerrchtE, TorralvaT, ManesF. Cognitive rehabilitation in posterior cortical atrophy. Neuropsychol. Rehab., 20(4), 12 (2008).
   Web of Science ®Google Scholar
• Cahn DA , SalmonDP, MonschAUet al. Screening for dementia of the Alzheimer type in the community: the utility of the clock drawing test. Arch. Clin. Neuropsychol., 11(6), 529–539 (1996).
   PubMed Web of Science ®Google Scholar
• Mercier L , DesrosiersJ, HébertR, RochetteA, DuboisMF. Normative data for the motor-free visual perception test-vertical. Phys. Occ. Ther. Geriatrics, 19(2), 39–50 (2001).
   Google Scholar
• Hartman-Maeir A , ArmonN, KatzN. The Kettle Test: A Cognitive Functional Screening Test Protocol.Helene University, Israel (2005).
   Google Scholar
• Shallice TIM , BurgessPW. Deficits in strategy application following frontal lobe damage in man. Brain, 114(2), 727–741 (1991).
   PubMed Web of Science ®Google Scholar
• Yong KXX , McCarthyID, PooleTet al. Navigational cue effects in Alzheimer’s disease and posterior cortical atrophy. Ann. Clin. Transl. Neurol., 5(6), 697–709 (2018).
   PubMed Web of Science ®Google Scholar
• Yong KXX , RajdevK, ShakespeareTJ, LeffAP, CrutchSJ. Facilitating text reading in posterior cortical atrophy. Neurology, 85(4), 229–248 (2015).
   Web of Science ®Google Scholar
• Gillen G . Chapter 1 – Overview of cognitive and perceptual rehabilitation. Cognitive and Perceptual Rehabilitation.Mosby, WA, USA, 1–31 (2009).
   Google Scholar
• Letts L , MinezesJ, EdwardsMet al. Effectiveness of interventions designed to modify and maintain perceptual abilities in people with Alzheimer’s disease and related dementias. Am. J. Occup. Ther., 65(5), 505–513 (2011).
   PubMed Web of Science ®Google Scholar
• Woods B , O’PhilbinL, FarrellEM, SpectorAE, OrrellM. Reminiscence therapy for dementia. Cochrane Database Syst. Rev. (3), CD001120 (2018).
   PubMed Web of Science ®Google Scholar
• Sitek EJ , NarozanskaE, PeplonskaBet al. A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene. PLoS ONE, 8(4), e61074 (2013).
   PubMed Web of Science ®Google Scholar
• Caixeta L . Huntington’s disease presenting as posterior cortical atrophy. Arq. Neuropsiquiatr., 69(2B), 407–408 (2011).
   PubMed Web of Science ®Google Scholar
• Depaz R , HaikS, Peoc’hKet al. Long-standing prion dementia manifesting as posterior cortical atrophy. Alzheimer Dis. Assoc. Disord., 26(3), 289–292 (2012).
   PubMed Web of Science ®Google Scholar
• Rossi G , BastoneA, PiccoliEet al. Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features. Neurobiol. Aging, 35(2), 408–417 (2014).
   PubMed Web of Science ®Google Scholar
• Schott JM , CrutchSJ, CarrasquillMMet al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer’s disease. Alzheimers Dement., 12(8), 862–871 (2016).
   PubMed Web of Science ®Google Scholar
• Pievani M , FilippiniN, vanden Heuvel MP, CappaSF, FrisoniGB. Brain connectivity in neurodegenerative diseases – from phenotype to proteinopathy. Nat. Rev. Neurol., 10(11), 620–633 (2014).
   PubMed Web of Science ®Google Scholar
• Ramanan VK , SaykinAJ. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am. J. Neurodegener. Dis., 2(3), 145–175 (2013).
   PubMedGoogle Scholar
• Sapolsky D , Domoto-ReillyK, DickersonBC. Use of the Progressive Aphasia Severity Scale (PASS) in monitoring speech and language status in PPA. Aphasiology, 28(8-9), 993–1003 (2014).
   PubMed Web of Science ®Google Scholar